Cencora(US:COR) ZACKS·2025-10-31 15:38Core Insights - Cencora (COR) is expected to report quarterly earnings of $3.79 per share, reflecting a year-over-year increase of 13.5% [1] - Projected revenues for the quarter are anticipated to be $83.16 billion, which represents a 5.2% increase from the previous year [1] - The consensus EPS estimate has been adjusted upward by 0.3% over the past 30 days, indicating a reassessment by analysts [1] Revenue Projections - Analysts project 'Revenue- Total International Healthcare Solutions' to reach $8.00 billion, indicating an 8.3% increase from the prior-year quarter [4] - The consensus for 'Revenue- Total U.S. Healthcare Solutions' is $75.11 billion, reflecting a year-over-year change of 4.8% [4] - 'Revenue- International Healthcare Solutions- Alliance Healthcare' is expected to be $6.47 billion, showing an 8.9% year-over-year increase [5] - 'Revenue- U.S. Healthcare Solutions- Animal Health' is estimated at $1.36 billion, suggesting a decline of 3.1% year over year [5] - The estimate for 'Revenue- U.S. Healthcare Solutions- Human Health' stands at $73.80 billion, indicating a 5% increase from the previous year [5] - 'Revenue- International Healthcare Solutions- Other Healthcare Solutions' is forecasted to reach $1.61 billion, reflecting an 11.7% increase [6] Operating Income Estimates - 'Operating income- Non-GAAP- International Healthcare Solutions' is projected to be $170.29 million, compared to $153.67 million from the previous year [6] - 'Operating income- Non-GAAP- U.S. Healthcare Solutions' is expected to arrive at $840.57 million, up from $697.38 million year-over-year [7] Stock Performance - Cencora shares have increased by 10.6% over the past month, outperforming the Zacks S&P 500 composite, which rose by 2.1% [7] - Cencora holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [7]